Ameritas Advisory Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Ameritas Advisory Services’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-384	Closed	-$12.9K	–	2442
2025 Q2	$12.9K	Buy	+384	New	+$12.2K	﹤0.01%	1915

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Ameritas Advisory Services's GNOM Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q3 2025, closing a stake of 384 shares — an estimated $12.9K sold.

Ameritas Advisory Services first reported a position in GNOM in Q2 2025 and held it in 1 quarter. The position peaked at $12.9K in Q2 2025. 41 funds tracked by Wall St. Rank hold GNOM as of Q3 2025.

Ameritas Advisory Services reported no remaining Global X Genomics & Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
Ameritas Advisory Services sold 384 Global X Genomics & Biotechnology ETF shares in Q3 2025, an estimated $12.9K.
Ameritas Advisory Services first reported a position in Global X Genomics & Biotechnology ETF in Q2 2025 and held it in 1 quarter.
Ameritas Advisory Services's Global X Genomics & Biotechnology ETF position peaked at $12.9K in Q2 2025.
41 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.